NF-L Antibodies

Santa Cruz Biotechnology offers a broad range of NF-L monoclonal antibodies for studying neurofilament light chain (NF-L). NF-L Antibodies are available for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). NF-L is a critical component of the neuronal cytoskeleton, playing a vital role in maintaining neuronal structure and function. Expression levels of NF-L are often associated with neurodegenerative diseases, making it a significant biomarker for conditions such as multiple sclerosis and amyotrophic lateral sclerosis. Understanding NF-L dynamics can provide insights into neuronal health and disease progression. Researchers can utilize NF-L monoclonal antibodies to investigate structural changes in neurons during development and disease states. Advanced imaging techniques combined with NF-L monoclonal antibodies enable detailed visualization of neuronal architecture and cytoskeletal organization. Monitoring NF-L levels helps track disease progression and evaluate potential therapeutic interventions. Santa Cruz Biotechnology monoclonal antibodies for NF-L support researchers worldwide in advancing neurodegenerative disease research and potential therapeutic developments.